Found: 3
Select item for more details and to access through your institution.
Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.
- Published in:
- Chemotherapy Research & Practice, 2012, p. 1, doi. 10.1155/2012/351210
- By:
- Publication type:
- Article
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mechanisms of resistance to vascular endothelial growth factor blockade.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3455, doi. 10.1002/cncr.26540
- By:
- Publication type:
- Article